Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Current recommendations and uncertainties for surgical treatment of infective endocarditis: a comparison of American and European cardiovascular guidelines

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. A double negative: culture-negative infective endocarditis

    Publikation: Bidrag til tidsskriftLederForskningpeer review

  2. Accelerated and personalized therapy for heart failure with reduced ejection fraction

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Heart transplantation: focus on donor recovery strategies, left ventricular assist devices, and novel therapies

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  1. Self-assessed health status and associated mortality in endocarditis: secondary findings from the POET trial

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Carpal Tunnel Syndrome in Patients Who Underwent Pacemaker Implantation and Relation to Amyloidosis, Heart Failure, and Mortality

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. A double negative: culture-negative infective endocarditis

    Publikation: Bidrag til tidsskriftLederForskningpeer review

  4. Analysis of Prescriptions for Dual Antiplatelet Therapy After Acute Ischemic Stroke

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Surgery is an effective therapy in the treatment of left-sided infective endocarditis (IE) in patients for whom antibiotic treatment alone is unlikely to be curative or may be associated with ongoing risk of complications. However, the interplay between indication for surgery, its risk, and timing is complex and there continue to be challenges in defining the effects of surgery on disease-related outcome. Guidelines published by the American College of Cardiology/American Heart Association and the European Society of Cardiology provide recommendations for the use of surgery in IE, but these are limited by a low level of evidence related to predominantly observational studies with inherent selection and survival biases. Evidence to guide the timing of surgery in IE is less robust, and predominantly based on expert consensus. Delays between IE diagnosis and recognition of an IE complication as a surgical indication and transfers to surgical centres also impact surgical timing. This comparison of the two guidelines exposes areas of uncertainty and gaps in current evidence for the use of surgery in IE across different indications, particularly related to its timing and consideration of operative risk.

OriginalsprogEngelsk
TidsskriftEuropean Heart Journal
Vol/bind43
Udgave nummer17
Sider (fra-til)1617-1625
Antal sider9
ISSN0195-668X
DOI
StatusUdgivet - 1 maj 2022

Bibliografisk note

© The Author(s) 2022. Published by Oxford University Press on behalf of European Society of Cardiology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

ID: 71203079